AIMS/HYPOTHESIS: Exposure to excess glucocorticoid is associated with pancreatic beta cell damage and decreased glucose-stimulated insulin secretion (GSIS). Inactive glucocorticoids (cortisone, 11-dehydrocorticosterone) are converted to active cortisol and corticosterone by 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1), which requires NADPH as cofactor, which is generated by hexose-6-phosphate dehydrogenase (H6PDH). We investigated the localisation and activity of 11beta-HSD1 within pancreatic islets, and determined its functional role in the regulation of insulin and glucagon secretion. METHODS: mRNA expression of 11beta-HSD1 (also known as HSD11B1), glucocorticoid receptor and H6PDH (also known as H6PD) in human pancreas and murine islets was examined by real-time PCR. 11beta-HSD1 protein levels were examined by immunohistochemistry and immunofluorescence. 11beta-HSD1 activity was assessed in intact tissue and isolated islets of wild-type (WT) and both 11beta-Hsd1- and H6pdh-null mice. Glucagon secretion and insulin secretion were analysed by RIA and ELISA respectively in isolated murine islets incubated with dexamethasone. RESULTS: 11beta-HSD1 co-localised with glucagon in the periphery of murine and human islets, but not with insulin or somatostatin. Dexamethasone, 11-dehydrocorticosterone and corticosterone induced a dose-dependent decrease in GSIS and glucagon secretion following low glucose stimulation. Reduction of 11beta-HSD1 activity with specific inhibitors or in experiments carried out in H6pdh-null mice reversed the effects of 11-dehydrocorticosterone, but had no effect following treatment with corticosterone. CONCLUSIONS/ INTERPRETATION: Local regeneration of glucocorticoid via 11beta-HSD1 within alpha cells regulates glucagon secretion and in addition may act in a paracrine manner to limit insulin secretion from beta cells.
AIMS/HYPOTHESIS: Exposure to excess glucocorticoid is associated with pancreatic beta cell damage and decreased glucose-stimulated insulin secretion (GSIS). Inactive glucocorticoids (cortisone, 11-dehydrocorticosterone) are converted to active cortisol and corticosterone by 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1), which requires NADPH as cofactor, which is generated by hexose-6-phosphate dehydrogenase (H6PDH). We investigated the localisation and activity of 11beta-HSD1 within pancreatic islets, and determined its functional role in the regulation of insulin and glucagon secretion. METHODS: mRNA expression of 11beta-HSD1 (also known as HSD11B1), glucocorticoid receptor and H6PDH (also known as H6PD) in humanpancreas and murine islets was examined by real-time PCR. 11beta-HSD1 protein levels were examined by immunohistochemistry and immunofluorescence. 11beta-HSD1 activity was assessed in intact tissue and isolated islets of wild-type (WT) and both 11beta-Hsd1- and H6pdh-null mice. Glucagon secretion and insulin secretion were analysed by RIA and ELISA respectively in isolated murine islets incubated with dexamethasone. RESULTS:11beta-HSD1 co-localised with glucagon in the periphery of murine and human islets, but not with insulin or somatostatin. Dexamethasone, 11-dehydrocorticosterone and corticosterone induced a dose-dependent decrease in GSIS and glucagon secretion following low glucose stimulation. Reduction of 11beta-HSD1 activity with specific inhibitors or in experiments carried out in H6pdh-null mice reversed the effects of 11-dehydrocorticosterone, but had no effect following treatment with corticosterone. CONCLUSIONS/ INTERPRETATION: Local regeneration of glucocorticoid via 11beta-HSD1 within alpha cells regulates glucagon secretion and in addition may act in a paracrine manner to limit insulin secretion from beta cells.
Authors: F Delaunay; A Khan; A Cintra; B Davani; Z C Ling; A Andersson; C G Ostenson; J Gustafsson; S Efendic; S Okret Journal: J Clin Invest Date: 1997-10-15 Impact factor: 14.808
Authors: Erin E Kershaw; Nicholas M Morton; Harveen Dhillon; Lynne Ramage; Jonathan R Seckl; Jeffrey S Flier Journal: Diabetes Date: 2005-04 Impact factor: 9.461
Authors: Hiroaki Masuzaki; Hiroshi Yamamoto; Christopher J Kenyon; Joel K Elmquist; Nicholas M Morton; Janice M Paterson; Hiroshi Shinyama; Matthew G F Sharp; Stewart Fleming; John J Mullins; Jonathan R Seckl; Jeffrey S Flier Journal: J Clin Invest Date: 2003-07 Impact factor: 14.808
Authors: Maureen Keller-Wood; Xiaodi Feng; Charles E Wood; Elaine Richards; Russell V Anthony; Geoffrey E Dahl; Sha Tao Journal: Am J Physiol Regul Integr Comp Physiol Date: 2014-06-11 Impact factor: 3.619
Authors: Johanna Maria Brix; Andrea Tura; Carsten Thilo Herz; Astrid Feder; Eva-Christina Krzizek; Verena Parzer; Giovanni Pacini; Bernhard Ludvik Journal: Obes Facts Date: 2021-09-08 Impact factor: 3.942
Authors: Gareth G Lavery; Agnieszka E Zielinska; Laura L Gathercole; Beverly Hughes; Nina Semjonous; Phillip Guest; Khalid Saqib; Mark Sherlock; Gary Reynolds; Stuart A Morgan; Jeremy W Tomlinson; Elizabeth A Walker; Elizabeth H Rabbitt; Paul M Stewart Journal: Endocrinology Date: 2012-05-03 Impact factor: 4.736
Authors: Sophie Turban; Xiaoxia Liu; Lynne Ramage; Scott P Webster; Brian R Walker; Donald R Dunbar; John J Mullins; Jonathan R Seckl; Nicholas M Morton Journal: Diabetes Date: 2012-02-07 Impact factor: 9.461
Authors: Jürgen G Okun; Sean Conway; Kathrin V Schmidt; Jonas Schumacher; Xiaoyue Wang; Roldan de Guia; Annika Zota; Johanna Klement; Oksana Seibert; Achim Peters; Adriano Maida; Stephan Herzig; Adam J Rose Journal: Mol Metab Date: 2015-07-30 Impact factor: 7.422